Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capicua transcriptional repressor pseudogene 26 (CICP26) is a presumed nonfunctional genomic sequence similar to the Capicua transcriptional repressor gene (CIC). The functional CIC gene encodes a highly conserved transcriptional repressor belonging to the high-mobility group (HMG) box superfamily, with roles in development, neuronal lineage progression, and disease (including certain cancers and spinocerebellar ataxia)[2][4][6]. However, as a pseudogene, CICP26 lacks the ability to produce a functional protein and does not serve as a therapeutic or research target. No aliases, biological activities, or disease connections are attributed specifically to CICP26. If you are seeking information about the functional gene (Capicua transcriptional repressor, CIC), it is a transcription factor involved in gene repression and has roles in cancer progression and neurodevelopmental diseases[2][4][6]. If more details are needed about the functional CIC protein, specify accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capicua transcriptional repressor pseudogene 26 (CICP26).